Hedera Dx: Getting everybody tested for cancer when it matters most.
Location: United States, Indiana, York
Employees: 11-50
Total raised: $13.859437M
Founded date: 2021
Investors 2
| Date | Name | Website |
| - | Bootstrap ... | bootstrap-... |
| 18.03.2022 | Air Street... | airstreet.... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.09.2022 | Seed | $13.859437... | - | einpresswi... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 17.10.2023 | Hedera Dx Launches Blood Based Cancer Testing | Liquid biopsies provide rapid, precise, non-invasive ways of assessing tumors and matching a patie... | startuptic... |
| 22.09.2022 | Hedera Dx raises €14 million in seed funding to accelerate g... | Liquid biopsy cancer testing is one of the most transformational innovations in healthcare for the n... | einpresswi... |
| 21.09.2022 | €14 million to accelerate global adoption of liquid biopsies... | According to cancer.org, 1 in 3 people will be diagnosed with cancer in their lifetime. To make su... | startuptic... |
| 21.09.2022 | Hedera Dx raises €14 million in seed funding to accelerate g... | Hedera Dx raises €14 million in seed funding to accelerate global adoption of liquid biopsies Wed, ... | news.cisio... |
| 10.01.2022 | Experienced top managers join start-ups | Dirk Klee, currently CEO Wealth Management & Investments of Barclays UK, will take over as Chi... | startuptic... |
| - | Hedera Dx | “Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to... | fastfounde... |